Advertisement
UK markets close in 3 hours 31 minutes
  • FTSE 100

    8,235.97
    +30.86 (+0.38%)
     
  • FTSE 250

    20,455.19
    +74.14 (+0.36%)
     
  • AIM

    774.69
    -2.81 (-0.36%)
     
  • GBP/EUR

    1.1832
    -0.0002 (-0.02%)
     
  • GBP/USD

    1.2681
    -0.0041 (-0.32%)
     
  • Bitcoin GBP

    52,184.95
    +785.55 (+1.53%)
     
  • CMC Crypto 200

    1,376.96
    -5.70 (-0.41%)
     
  • S&P 500

    5,487.03
    +13.80 (+0.25%)
     
  • DOW

    38,834.86
    +56.76 (+0.15%)
     
  • CRUDE OIL

    81.68
    +0.11 (+0.13%)
     
  • GOLD FUTURES

    2,353.90
    +7.00 (+0.30%)
     
  • NIKKEI 225

    38,633.02
    +62.26 (+0.16%)
     
  • HANG SENG

    18,335.32
    -95.07 (-0.52%)
     
  • DAX

    18,158.70
    +90.79 (+0.50%)
     
  • CAC 40

    7,642.84
    +72.64 (+0.96%)
     

Vor Bio to Participate in Upcoming Investor Conferences

Vor Biopharma
Vor Biopharma

CAMBRIDGE, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming investor conferences:

The Citizens JMP Life Sciences Conference
Fireside Chat: Tuesday, May 14, 2024 at 11:00 am ET
Location: New York, NY

A live webcast and archived replay of the fireside chat will be available on the investors section of www.vorbio.com.

H.C. Wainwright 2nd Annual BioConnect Investor Conference
Fireside Chat: Monday, May 20, 2024 at 10:30 am ET
Location: New York, NY

About Vor Bio
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Contact:

Media & Investors
Sarah Spencer
+1 857-242-6076
sspencer@vorbio.com